CymitQuimica logo

CAS 112471-14-4

:

Sortieren nach

Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
2 Produkte.
  • N-(Diphenoxymethylene)-methanesulfonamide

    Kontrolliertes Produkt
    CAS:
    <p>Applications N-(Diphenoxymethylene)-methanesulfonamide is used in the synthesis of analog of ranitidine, N-2-(2-Hydroxy-2-phenyl)ethyl-N’’-(methanesulfonyl)guanidine, which possesses antiulcer activity.Also, it is an intermediate used in the synthesis of Osutidine (O703905), which can be used in the biological study of studies on cAMP generation in hepa cells expressing histamine H2 receptor antagonism by T-593. Anti-ulcer drug that is structurally related to Rantidine (R120000).<br>References Shibata, H., et al.: Yakugaku Zasshi, 118, 88-104 (1998); Tashiro, T., et al.: Pharmacology, 59, 1 (1999)<br></p>
    Formel:C14H13NO4S
    Farbe und Form:Neat
    Molekulargewicht:291.322

    Ref: TR-D489395

    100mg
    1.022,00€
  • N-(Diphenoxymethylene)-methanesulfonamide

    CAS:
    <p>N-(Diphenoxymethylene)-methanesulfonamide is a potent cancer kinase inhibitor that has been shown to induce apoptosis in human cancer cells. It is an analog of the anticancer drug staurosporine and inhibits a wide range of kinases, including cyclin-dependent kinases (CDKs) and protein kinase C. N-(Diphenoxymethylene)-methanesulfonamide has demonstrated significant activity against various tumor types in Chinese hamster ovary cells and has been shown to be effective in inhibiting the growth of several different cancer cell lines. This inhibitor can also be found in urine samples, indicating its potential use as a biomarker for cancer diagnosis and treatment monitoring. Overall, N-(Diphenoxymethylene)-methanesulfonamide represents a promising new class of anticancer agents with broad-spectrum kinase inhibition activity.</p>
    Formel:C14H13NO4S
    Reinheit:Min. 95%
    Molekulargewicht:291.32 g/mol

    Ref: 3D-MEA47114

    25mg
    712,00€
    50mg
    1.018,00€
    100mg
    1.416,00€